Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Tables)

v3.20.1
Stockholders' Equity (Tables)
 12 Months Ended
Dec. 31, 2019
Stockholders' Equity (Tables) [Line Items]  
Share-based Payment Arrangement, Option, Activity [Table Text Block]
    Warrant Grants     Stock Option Grants     Restricted Stock Units  
    Number of
shares
subject to
warrants		     Weighted-
average
exercise
price per
share		     Number of
shares
subject to
options		     Weighted-
average
exercise
price per
share		     Number of
shares
subject to
restricted
stock units		     Weighted-
average
exercise
price per
share		  
Balance at December 31, 2018     236,825     $ 26.00       135,023     $ 7.70       0     $           -  
Granted     1,112,220       5.67       203,572       3.65       730,303       -  
Exercised     (11,075 )     5.51       -       -       -       -  
Cancelled/Forfeited     (26,054 )     5.51       -       -       (100,000 )     -  
Balance at December 31, 2019     1,311,916     $ 9.35       338,595     $ 5.96       630,303     $ -  
Exercisable at December 31, 2019     1,311,916     $ 9.35       226,095     $ 6.57       630,303     $ -  
Schedule of stock-based compensation expense [Table Text Block]
    Year Ended December 31,  
    2019     2018  
Stock option awards   $ 584,280     $    -  
Common stock    

1,575,044

       -  
Transfer of common stock by founders to contractors     5,322,930       -  
Total   $

7,482,254

     $ -  
Stock Options [Member]  
Stockholders' Equity (Tables) [Line Items]  
Share-based Payment Arrangement, Option, Activity [Table Text Block]
    Year Ended December 31,  
    2019     2018  
Stock-based compensation expense   $

7,482,254

     $    -